105 related articles for article (PubMed ID: 2171760)
1. Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas.
Gibson SL; VanDerMeid KR; Murant RS; Raubertas RF; Hilf R
Cancer Res; 1990 Nov; 50(22):7236-41. PubMed ID: 2171760
[TBL] [Abstract][Full Text] [Related]
2. Effects of laser photodynamic therapy on tumor phosphate levels and pH assessed by 31P-NMR spectroscopy.
Gibson SL; Ceckler TL; Bryant TG; Hilf R
Cancer Biochem Biophys; 1989 Oct; 10(4):319-28. PubMed ID: 2533522
[TBL] [Abstract][Full Text] [Related]
3. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fluorescence and photodynamic activities of whole hematoporphyrin derivative and its enriched active components.
Nelson JS; Wright WH; Berns MW
J Natl Cancer Inst; 1985 Dec; 75(6):1135-40. PubMed ID: 2933546
[TBL] [Abstract][Full Text] [Related]
5. Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230AC mammary adenocarcinomas of rats.
Hilf R; Smail DB; Murant RS; Leakey PB; Gibson SL
Cancer Res; 1984 Apr; 44(4):1483-8. PubMed ID: 6231099
[TBL] [Abstract][Full Text] [Related]
6. Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas.
Gibson SL; Murant RS; Hilf R
Cancer Res; 1988 Jun; 48(12):3360-6. PubMed ID: 2836053
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
8. Experimental research photodynamic effects in perifocal, oedematous brain tissue.
Goetz C; Hasan A; Stummer W; Heimann A; Kempski O
Acta Neurochir (Wien); 2002 Feb; 144(2):173-9; discussion 179. PubMed ID: 11862518
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
Henderson BW; Sitnik-Busch TM; Vaughan LA
Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
[TBL] [Abstract][Full Text] [Related]
10. Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
Gibson SL; van der Meid KR; Murant RS; Hilf R
Br J Cancer; 1990 Apr; 61(4):553-7. PubMed ID: 2139578
[TBL] [Abstract][Full Text] [Related]
11. Relationship of mitochondrial function and cellular adenosine triphosphate levels to hematoporphyrin derivative-induced photosensitization in R3230AC mammary tumors.
Hilf R; Murant RS; Narayanan U; Gibson SL
Cancer Res; 1986 Jan; 46(1):211-7. PubMed ID: 3940191
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
13. Fluence rate effects in photodynamic therapy of multicell tumor spheroids.
Foster TH; Hartley DF; Nichols MG; Hilf R
Cancer Res; 1993 Mar; 53(6):1249-54. PubMed ID: 8443805
[TBL] [Abstract][Full Text] [Related]
14. Photosensitizing effects of Photofrin II on the site-selected mitochondrial enzymes adenylate kinase and monoamine oxidase.
Murant RS; Gibson SL; Hilf R
Cancer Res; 1987 Aug; 47(16):4323-8. PubMed ID: 3038310
[TBL] [Abstract][Full Text] [Related]
15. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
16. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
17. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
19. Improvement of systemic 5-aminolevulinic acid-based photodynamic therapy in vivo using light fractionation with a 75-minute interval.
de Bruijn HS; van der Veen N; Robinson DJ; Star WM
Cancer Res; 1999 Feb; 59(4):901-4. PubMed ID: 10029082
[TBL] [Abstract][Full Text] [Related]
20. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
